Skip to main content
. 2009 May 11;19(12):2827–2837. doi: 10.1093/cercor/bhp065

Figure 4.

Figure 4.

LC stimulation–induced CA1 LTD is NR2B and β-adrenoceptor dependent. (A) NMDA receptor subunit 2B (NR2B)–selective antagonist ifenprodil (4.9 μg) and (B) β-adrenoceptor antagonist propranolol (2 μg) block LC stimulation–induced SC–CA1 LTD. (C, D, insets), Analog traces representing SC–CA1 field potentials before LC stimulation, 4 h and 24 h after LC stimulation. Top row: LC stimulation control. Bottom row: LC stimulation with drug application. Calibration: vertical bar, 1 mV; horizontal bar, 3 ms. The mean fEPSP slope is displayed along with the corresponding SEM.